Balen Sanja, Caser Linda, Ivanković Edita, Samardzija Marina, Ivanković Zdravko, Vcev Aleksandar
Clinical Institute for Transfusion Medicine, University Hospital Center Rijeka, Rijeka, Croatia.
Coll Antropol. 2009 Dec;33(4):1375-81.
The aim of this investigation was to assess the rate and appropriate use of fresh frozen plasma (FFP) at the Clinical Hospital Center Rijeka in two six-month periods, at an interval of 5 years, before and after introducing clinical standards for transfusion practice and hemovigilance, and to evaluate the results of applied measures. We studied 315 patients transfused with 1341 doses of FFP in two six-month periods from September to February of 1999/2000 and 2004/2005. The first period (1999/00) of the study was retrospective and 226 patients were transfused with 928 FFP units. The second period (2004/05) was prospective and we studied 89 patients transfused with 413 units. In the first period blood bank records were retrospectively reviewed and in the second period all FFP requests, performed coagulation tests and transfusion episodes were prospectively analyzed. The number of inappropriate transfusions decreased from 39.8% to 23.6%. In most patients (85.1%), coagulation tests were made prior to FFP transfusion. The number of patients transfused with one and two FFP doses decreased, while those transfused with three or more doses increased. Most of the appropriately transfused patients were those with active bleeding due to coagulation factor deficiency and massive transfusions. The least were those requiring reversal of warfarin effect. Our results demonstrated a decrease in the number of patients treated with FFP in the second period. The introduction of clinical standards of good transfusion practice and hemovigilance showed positive effects. Considering that there was a number of inappropriately transfused patients continued education of all health personnel engaged in transfusion treatment is evidently necessary.
本研究的目的是评估里耶卡临床医院中心在引入输血实践和血液警戒临床标准前后,两个为期六个月的时间段(间隔5年)内新鲜冰冻血浆(FFP)的使用频率和合理使用情况,并评估所采取措施的效果。我们研究了1999/2000年9月至2月以及2004/2005年9月至2月这两个为期六个月时间段内接受1341剂FFP输血的315例患者。研究的第一个时间段(1999/00)为回顾性研究,226例患者接受了928单位FFP输血。第二个时间段(2004/05)为前瞻性研究,我们研究了接受413单位FFP输血的89例患者。第一个时间段对血库记录进行回顾性审查,第二个时间段对所有FFP申请、进行的凝血试验和输血事件进行前瞻性分析。不当输血的比例从39.8%降至23.6%。大多数患者(85.1%)在输注FFP前进行了凝血试验。接受1剂和2剂FFP输血的患者数量减少,而接受3剂或更多剂FFP输血的患者数量增加。大多数合理输血的患者是因凝血因子缺乏导致活动性出血和大量输血的患者。最少的是需要逆转华法林作用的患者。我们的结果表明,第二个时间段接受FFP治疗的患者数量有所减少。引入良好输血实践和血液警戒的临床标准显示出积极效果。鉴于仍有一些患者存在不当输血情况,显然有必要对所有从事输血治疗的医护人员进行继续教育。